These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

228 related items for PubMed ID: 18288085

  • 1. Human abuse liability of the smoking cessation drug varenicline in smokers and nonsmokers.
    McColl SL, Burstein AH, Reeves KR, Billing CB, Stolar M, Sellers EM.
    Clin Pharmacol Ther; 2008 Apr; 83(4):607-14. PubMed ID: 18288085
    [Abstract] [Full Text] [Related]

  • 2. Varenicline for smoking cessation: a placebo-controlled, randomized study.
    Wang C, Xiao D, Chan KP, Pothirat C, Garza D, Davies S.
    Respirology; 2009 Apr; 14(3):384-92. PubMed ID: 19192221
    [Abstract] [Full Text] [Related]

  • 3. Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up.
    Nides M, Oncken C, Gonzales D, Rennard S, Watsky EJ, Anziano R, Reeves KR.
    Arch Intern Med; 2009 Apr; 166(15):1561-8. PubMed ID: 16908788
    [Abstract] [Full Text] [Related]

  • 4. Single-dose pharmacokinetics of varenicline, a selective nicotinic receptor partial agonist, in healthy smokers and nonsmokers.
    Faessel HM, Smith BJ, Gibbs MA, Gobey JS, Clark DJ, Burstein AH.
    J Clin Pharmacol; 2006 Sep; 46(9):991-8. PubMed ID: 16920893
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation.
    Oncken C, Gonzales D, Nides M, Rennard S, Watsky E, Billing CB, Anziano R, Reeves K.
    Arch Intern Med; 2006 Sep; 166(15):1571-7. PubMed ID: 16908789
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Varenicline: a selective alpha4beta2 nicotinic acetylcholine receptor partial agonist approved for smoking cessation.
    Lam S, Patel PN.
    Cardiol Rev; 2007 Sep; 15(3):154-61. PubMed ID: 17438382
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of varenicline on heart rate variability in healthy smokers and nonsmokers.
    Ari H, Celiloğlu N, Ari S, Coşar S, Doganay K, Bozat T.
    Auton Neurosci; 2011 Oct 28; 164(1-2):82-6. PubMed ID: 21664880
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of varenicline for smoking cessation.
    Hays JT, Ebbert JO, Sood A.
    Am J Med; 2008 Apr 28; 121(4 Suppl 1):S32-42. PubMed ID: 18342165
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of varenicline for smoking cessation in patients with schizophrenia or schizoaffective disorder.
    Williams JM, Anthenelli RM, Morris CD, Treadow J, Thompson JR, Yunis C, George TP.
    J Clin Psychiatry; 2012 May 28; 73(5):654-60. PubMed ID: 22697191
    [Abstract] [Full Text] [Related]

  • 16. A double-blind randomized placebo-controlled pilot study of neuropsychiatric adverse events in abstinent smokers treated with varenicline or placebo.
    Garza D, Murphy M, Tseng LJ, Riordan HJ, Chatterjee A.
    Biol Psychiatry; 2011 Jun 01; 69(11):1075-82. PubMed ID: 21295286
    [Abstract] [Full Text] [Related]

  • 17. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers.
    Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C.
    Biol Psychiatry; 2010 Apr 15; 67(8):715-21. PubMed ID: 20207347
    [Abstract] [Full Text] [Related]

  • 18. Interference with smoking-cessation effects of varenicline after administration of immediate-release amphetamine-dextroamphetamine.
    Whitley HP, Moorman KL.
    Pharmacotherapy; 2007 Oct 15; 27(10):1440-5. PubMed ID: 17896898
    [Abstract] [Full Text] [Related]

  • 19. Observational study of safety and efficacy of varenicline for smoking cessation among Filipino smokers.
    Park PW, Casiano EM, Escoto L, Claveria AM.
    Curr Med Res Opin; 2011 Oct 15; 27(10):1869-75. PubMed ID: 21838412
    [Abstract] [Full Text] [Related]

  • 20. Practical implementation of varenicline as an aid to smoking cessation in clinical practice.
    Tonstad S.
    Pneumologia; 2009 Oct 15; 58(3):167-74. PubMed ID: 19817313
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.